SCHEMBL6623089

SCHEMBL6623089

COc1cnc(Cl)n2c(N)nnc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 1/20 0.38
PARP1 P09874 1/20 0.38
PARP6 Q2NL67 1/20 0.38
PARP15 Q460N3 1/20 0.38
PARP14 Q460N5 1/20 0.38
PARP10 Q53GL7 1/20 0.38
TIPARP Q7Z3E1 1/20 0.38
PARP16 Q8N5Y8 1/20 0.38
PARP12 Q9H0J9 1/20 0.38
TNKS2 Q9H2K2 1/20 0.38
PARP11 Q9NR21 1/20 0.38
PARP2 Q9UGN5 1/20 0.38
PARP4 Q9UKK3 1/20 0.38
PARP3 Q9Y6F1 1/20 0.38
CHEK1 O14757 2/20 0.35
GRK5 P34947 2/20 0.35
CSNK1A1 P48729 2/20 0.35
LIMK1 P53667 2/20 0.35
TYRO3 Q06418 2/20 0.35
LRRK2 Q5S007 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6622790 0.81 TNKS (0.39) TNKSPARP1PARP6PARP15PARP14
SCHEMBL6626498 0.78 PARP2 (0.39) TNKSPARP1PARP6PARP15PARP14
Bromide SCHEMBL4070073 0.76 PARP2 (0.38) TNKSPARP1PARP6PARP15PARP14
SCHEMBL841386 0.69 HSP90AB1 (0.39) JAK2P2RX3P2RX2
SCHEMBL23330631 0.68 MAPT (0.37) PARP15PARP10TNKS2PARP2MAPT
SCHEMBL6623696 0.66 APLNR (0.35) TNKSPARP1PARP6PARP15PARP14
Bromide SCHEMBL7865974 0.63 ALDH1A1 (0.35) MAPTALDH1A1
SCHEMBL2441110 0.61 ALDH1A1 (0.37) FGFR1MAPTGAAKDM4EALDH1A1
SCHEMBL4059934 0.60 CHEK1 (0.35) CHEK1GRK5CSNK1A1LIMK1TYRO3
SCHEMBL2172710 0.60 NOS3 (0.34) TNKSPARP1PARP15PARP14PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6362335-B1 None US disclosed
EP-1289994-B1 PROCESS FOR THE PREPARATION OF 2-AMINO-5,8-DIMETHOXY 1,2,4]TRIAZOLO 1,5-c]PYRIMIDINE DOW AGROSCIENCES LLC (US) 2004-03-17 EP disclosed
US-6362335-B2 CONTACTING 3-AMINO-8-METHOXY(1,2,4) TRIAZOLO(4,3-C)PYRIMIDINE COMPOUNDS WITH SODIUM OR POTASSIUM METHOXIDE IN AN ALCOHOL SOLVENT DOW AGROSCIENCES LLC 2002-03-26 US disclosed
US-20020013230-A1 Process for the preparation of 2-amino-5, 8-dimethoxy (1,2,4) triazolo (1,5-c) pyrimidine CORTEVA AGRISCIENCE LLC 2002-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020013230-A1 Process for the preparation of 2-amino-5, 8-dimethoxy (1,2,4) triazolo (1,5-c) pyrimidine PYM1, THPO, ADH1C TNKS 165/4885PARP1 493/4885PARP6 1338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.